Evidence map›Paper›PMID 30200487›Full record

ArticleInternational journal of environmental research and public health2018

Seroprevalence of Markers of Hepatitis B Virus Infection, Associated Factors, and Vaccination Status in Young Adults in Arkhangelsk, Northwest Russia: A Population-Based Cross-Sectional Study.

Tatiana Balaeva, Andrej M Grjibovski, Olga Samodova, Anatoly Sannikov, Elise Klouman

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Tatiana BalaevaDepartment of Community Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway. arkhangelsk.tatiana@rambler.ru.
Andrej M GrjibovskiCentral Scientific Research Laboratory, Northern State Medical University, 163000 Arkhangelsk, Russia. andrej.grjibovski@gmail.com.ORCID 0000-0002-5464-0498
Olga SamodovaDepartment of Infectious Diseases, Northern State Medical University, 163000 Arkhangelsk, Russia. ovsamodova@mail.ru.
Anatoly SannikovInstitute of Public Health, Northern State Medical University, 163000 Arkhangelsk, Russia. jsannikov@yandex.ru.
Elise KloumanDepartment of Community Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway. elise.klouman@gmail.com.
Northern State Medical University · RUInternational Institute of Management Arkhangelsk · RUNorth-Eastern Federal University · RUUiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Russia had a high incidence of hepatitis B virus (HBV) infection before the vaccination campaigns of 1997, 2001, 2007, which targeted newborns, adolescents, and adults, respectively. The aim of our study was to assess the prevalence of serological markers of HBV infection, associated factors, and vaccination status among young adults in Arkhangelsk, Northwest Russia. In this cross-sectional, population-based study, we used a quota sampling method to recruit 1243 adults aged 18⁻39 years. Participants completed a self-administrated questionnaire and were tested for hepatitis B markers. Associations between positivity for markers and selected sociodemographic and behavioral factors were studied by logistic regression. 10.9% of our participants were positive for at least one marker of hepatitis B, 1.2% were positive for HBsAg, and 42.1% were negative for all markers. In multivariable logistic regression analyses, age 30⁻34 years; lack of self-reported vaccination; and having ≥2 sexual partners in the last 6 months were associated with positivity for markers of hepatitis B. Hepatitis B vaccination was confirmed in 46.9% of participants. Although half of our study sample was vaccinated, four in 10 were still susceptible to infection and more than one participant in 100 showed evidence of an active infection.

Indexed as

AdolescentAdultBiomarkersCross-Sectional StudiesFemaleHepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B virusHumansLogistic ModelsMalePrevalenceRussiaSeroepidemiologic StudiesSexual PartnersBiomarkersHepatitis B AntibodiesHepatitis B Surface Antigenshepatitis B prevalencehepatitis B vaccinationpopulation-based studyRussia

Identifiers

PMID30200487
PMCPMC6163199
OpenAlexW2889108884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.